Despite these obstacles, current clinical studies suggest that serum and plasma NfL are among the most promising blood-based biomarkers for ischemic stroke prediction, especially when combined with imaging and clinical parameters in multiple-factor predictive frameworks. The gene discussed is NEFL; the disease is ischemic stroke.